C Jalles, M Lepelley, S Mouret,
J Charles, MT Leccia… - Therapies, 2022 - Elsevier
Background Janus kinase (JAK) inhibitors are targeted therapies with a potential
imunomodulatory and anti-inflammatory effect, indicated in various dysimmune pathologies …